MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 1

MStranslate
March 13, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
1 Comment
The following is part of an MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies and drugs for human disease. Dr. Travis Stiles is a...
research

Why Multiple Sclerosis Research Needs All Of Us

MStranslate
March 6, 2018
Community, Opinion, Research
Medical research is important. Researchers are important. We need to value and support the work that researchers do. Researchers' work is giving us the best chance of finding answers that will help improve...
multiple sclerosis

Support the Future of Multiple Sclerosis Research

MStranslate
February 28, 2018
Community, Research, Treatments
...
Support MS Research

How To Directly Support Multiple Sclerosis Research

MStranslate
January 25, 2018
Community, Research
MStranslate is proud to announce the launch of a new, exciting initiative, designed to strengthen the connection between the multiple sclerosis community and MS researchers. For the first time via...
exercise

Study Investigates Exercise Conditions for PwMS

MStranslate
January 12, 2018
Exercise, Lifestyle, Research
Research Summary: Environmental temperature and exercise modality independently impact central and muscle fatigue among people with multiple sclerosis Whilst more and more studies are suggesting that...

Multiple Sclerosis Research 2017: Predictions Revisited

MStranslate
December 20, 2017
Epstein-Barr virus, Opinion, Research
On January 10, 2017, I wrote an opinion piece about what I thought would be the biggest developments in multiple sclerosis research in 2017.  Now, 345 days later, it seems like a good opportunity to revisit...
diet

Diet Quality is Important in Multiple Sclerosis

MStranslate
December 10, 2017
Diet, Lifestyle, Research
This year we have seen a large increase in the focus of research into how lifestyle factors may benefit people living with multiple sclerosis.  In particular, studies investigating the effect of diet in MS...
exercise

Exercise May Improve Brain Connectivity in PwMS

MStranslate
November 14, 2017
Exercise, Lifestyle, Research
There is growing evidence for the benefits of exercise for people with multiple sclerosis. Studies have shown that the advantages gained from regular physical activity can include decreasing fatigue, improving...
comorbidities

The Importance of Overall Health in Multiple Sclerosis

MStranslate
November 1, 2017
Lifestyle, Research
Thankfully, we are beginning to see an increased amount of research being conducted to examine the benefits of an overall health approach to the management of multiple sclerosis.  In particular, there is an...
animal models

Animal Models of Multiple Sclerosis – Are They Useful?

MStranslate
October 3, 2017
Research, Understanding Science
Animal models of multiple sclerosis are not perfect.  I think that is an important first point to make.  As we still don’t know what causes multiple sclerosis, we can’t replicate the disease exactly in...
  1. 9
  2. 10
  3. 11
  4. 12
  5. 13
  6. 14
  7. 15

Recent Posts

  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib

Recent Comments

  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026
  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date

Calendar

August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
« Jul    

Archives

Categories

Posts

  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.